Roche Holding AG ROG-CH:Swiss Exchange

*Data is delayed | CHF
Last | 11/26/21 CET
358.60quote price arrow down-3.45 (-0.95%)
Volume
1,125,058
52 week range
293.05 - 378.95
Loading...
  • Open356.00
  • Day High362.00
  • Day Low355.35
  • Prev Close362.05
  • 52 Week High378.95
  • 52 Week High Date11/04/21
  • 52 Week Low293.05
  • 52 Week Low Date02/26/21

Key Stats

  • Market Cap340,921.48M
  • Shares Out854.26M
  • 10 Day Average Volume885,562.58
  • Dividend9.10
  • Dividend Yield2.54%
  • Beta0.09
  • YTD % Change16.05

KEY STATS

  • Open356.00
  • Day High362.00
  • Day Low355.35
  • Prev Close362.05
  • 52 Week High378.95
  • 52 Week High Date11/04/21
  • 52 Week Low293.05
  • 52 Week Low Date02/26/21
  • Market Cap340,921.48M
  • Shares Out854.26M
  • 10 Day Average Volume885,562.58
  • Dividend9.10
  • Dividend Yield2.54%
  • Beta0.09
  • YTD % Change16.05

RATIOS/PROFITABILITY

  • EPS (TTM)16.52
  • P/E (TTM)21.71
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including...
Christoph Franz Ph.D.
Non-Executive Chairman
Alan Hippe
Chief Financial Officer
Claudia Boeckstiegel
General Counsel
Address
Grenzacherstr. 124
Basel
4058
Switzerland